P48 Long-term efficacy of dupilumab in patients with moderate-to-severe asthma in the LIBERTY ASTHMA TRAVERSE open-label extension study: improvements in asthma control and health-related quality of life

Diagnostics and monitoring of asthma and co-morbidities Pub Date : 2021-11-01 DOI:10.1136/thorax-2021-btsabstracts.158

I. Pavord, M. Wechsler, L. Ford, J. Maspero, D. Langton, C. Domingo, A. Papi, A. Bourdin, H. Watz, X. Mao, N. Amin, M. Hardin, Y. Zhang, Ah Khan

引用次数: 0

查看原文本刊更多论文

P48 LIBERTY asthma TRAVERSE开放标签扩展研究中dupilumab对中重度哮喘患者的长期疗效:哮喘控制和健康相关生活质量的改善

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

自引率

0.00%

发文量